2-Morpholino-Pyrido[3,2-d]Pyrimidine

European patent · EP2396322 · In force

Register entry

Publication number
EP2396322
Application number
EP10702322
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 4, 2010
Published
Dec 21, 2011
Granted
Feb 3, 2016
Protection ends at the latest
Feb 3, 2030
Next annual fee due
Feb 28, 2027
IPC classes
C07D 471/04 (2006.01)
A61K 31/519 (2006.01)
Priority
EP 09152709 12.02.2009
US 207744 P 17.02.2009
PCT application
PCT/EP2010/051373 04.02.2010
PCT publication
WO2010/091996 19.08.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Dec 20, 2016

    Agent entered

    Representative
    Merck Serono S.A., Intellectual Property, Zone Industrielle de l'Ouriettaz, 1170 Aubonne

    Published in Swissreg on 20.12.2016

  6. Feb 3, 2016

    Granted

    Published in Swissreg on 03.02.2016

Parties

Holder

Merck Serono SA

Centre Industriel, 1267 Coinsins, Vaud

Agent

Merck Serono S.A. Intellectual Property

Zone Industrielle de l'Ouriettaz, 1170 Aubonne

Inventor

MONTAGNE, Cyril

F-01630 Saint-Genis-Pouilly, FR

BOMBRUN, Agnès

1292 Chambésy, FR

DESFORGES-BOUSCARY, Gwenaelle

F-74100 Annemasse, FR

QUATTROPANI, Anna

CH- 1207 Geneva

GAILLARD, Pascale

F-74160 Collonge-sous-Salève, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.